CRM Stock Analysis: Salesforce.com | NYSE
Software - Application | NYSE, USA | Market Cap: 194.796m USD | 12M Return: -4.5% | US79466L3024 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 2.49B
EPS Trend: 97.7%
Qual. Beats: 5
Rev. Trend: 99.7%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Salesforce, Inc. is a leading provider of cloud-based customer relationship management (CRM) software, operating across the United States, Europe, and Asia Pacific. Its portfolio centers on the Agentforce platform, which enables enterprises to build and deploy autonomous AI agents that collaborate with human workers across sales, service, and operations. Supporting products include Data 360 and Informatica for AI-powered data management, Slack as a collaborative workspace for the agentic enterprise, and solutions for marketing, commerce, analytics, field service, and small and medium-sized businesses through Salesforce Starter. The company serves clients in financial services, healthcare and life sciences, manufacturing, automotive, and government sectors. Salesforce was incorporated in 1999 and is headquartered in San Francisco, California.
As a large-cap Application Software company in the Information Technology sector, Salesforce operates primarily on a subscription-based Software-as-a-Service (SaaS) model, which generates recurring revenue through multi-year enterprise contracts. Its recent strategic emphasis on agentic AI represents a broader industry shift toward embedding generative and autonomous AI capabilities directly into core business workflows.
- Agentforce AI bookings accelerate as enterprise adoption scales
- Operating margin expansion drives double-digit EPS growth
- Informatica acquisition strengthens data platform integration capabilities
| Net Income: 9.66b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 1.02 > 1.0 |
| NWC/Revenue: -9.68% < 20% (prev 7.09%; Δ -16.77% < -1%) |
| CFO/TA 0.14 > 3% & CFO 15.8b > Net Income 9.66b |
| Net Debt (32.8b) to EBITDA (16.8b): 1.96 < 3 |
| Current Ratio: 0.84 > 1.5 & < 3 |
| Outstanding Shares: last quarter (821.0m) vs 12m ago -14.66% < -2% |
| Gross Margin: 77.28% > 18% (prev 77.65%; Δ -0.37% > 0.5%) |
| Asset Turnover: 42.41% > 50% (prev 40.48%; Δ 1.93% > 0%) |
| Interest Coverage Ratio: 39.65 > 6 (EBIT TTM 12.8b / Interest Expense TTM 324.0m) |
| A: -0.04 (Total Current Assets 22.1b - Total Current Liabilities 26.3b) / Total Assets 110b |
| B: 0.25 (Retained Earnings 27.1b / Total Assets 110b) |
| C: 0.12 (EBIT TTM 12.8b / Avg Total Assets 104b) |
| D: 0.54 (Book Value of Equity 38.4b / Total Liabilities 71.2b) |
| Altman-Z'' = 1.95 = BBB |
| DSRI: 1.02 (Receivables 6.32b/5.60b, Revenue 43.9b/39.5b) |
| GMI: 1.00 (GM 77.65% / 77.28%) |
| AQI: 1.10 (AQ_t 0.75 / AQ_t-1 0.69) |
| SGI: 1.11 (Revenue 43.9b / 39.5b) |
| TATA: -0.06 (NI 9.66b - CFO 15.8b) / TA 110b) |
| Beneish M = -2.88 (Cap -4..+1) = A |
As of October 09, 2026, the stock is trading at USD 227.80 with a total of 6,155,822 shares traded. Over the past week, the price has changed by -3.76%, over one month by -8.40%, over three months by +36.99% and over the past year by -4.45%.
Current recommended Stop Loss: 217.60 (which is 4.5% or 1.2 ATR below the current price).
Salesforce.com has received a consensus analysts rating of 4.24. Therefore, it is recommended to buy CRM.
- StrongBuy: 32
- Buy: 6
- Hold: 15
- Sell: 2
- StrongSell: 0
| Analysts Target Price | 282.6 | 24% |
P/E Trailing = 21.2659
P/E Forward = 13.986
P/S = 4.4334
P/B = 5.0026
P/EG = 0.7791
Revenue TTM = 43.9b USD
EBIT TTM = 12.8b USD
EBITDA TTM = 16.8b USD
Long Term Debt = 39.3b USD (from longTermDebt, last quarter)
Short Term Debt = 531.0m USD (from shortTermDebt, last quarter)
Debt = 44.2b USD (from shortLongTermDebtTotal, last quarter) + Leases 2.46b
Net Debt = 32.8b USD (calculated: Debt 44.2b - CCE 11.4b)
Enterprise Value = 228b USD (195b + Debt 44.2b - CCE 11.4b)
Interest Coverage Ratio = 39.65 (Ebit TTM 12.8b / Interest Expense TTM 324.0m)
EV/FCF = 15.02x (Enterprise Value 228b / FCF TTM 15.2b)
FCF Yield = 6.66% (FCF TTM 15.2b / Enterprise Value 228b)
FCF Margin = 34.49% (FCF TTM 15.2b / Revenue TTM 43.9b)
Net Margin = 21.99% (Net Income TTM 9.66b / Revenue TTM 43.9b)
Gross Margin = 77.28% ((Revenue TTM 43.9b - Cost of Revenue TTM 9.98b) / Revenue TTM)
Gross Margin QoQ = 76.65% (prev 76.92%)
Tobins Q-Ratio = 2.08 (Enterprise Value 228b / Total Assets 110b)
Interest Expense / Debt = 0.73% (Interest Expense 324.0m / Debt 44.2b)
Taxrate = 22.16% (2.75b / 12.4b)
NOPAT = 10.00b (EBIT 12.8b * (1 - 22.16%))
Current Ratio = 0.84 (Total Current Assets 22.1b / Total Current Liabilities 26.3b)
Debt / Equity = 1.15 (Debt 44.2b / totalStockholderEquity, last quarter 38.4b)
Debt / EBITDA = 1.96 (Net Debt 32.8b / EBITDA 16.8b)
Debt / FCF = 2.16 (Net Debt 32.8b / FCF TTM 15.2b)
Total Stockholder Equity = 47.9b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.33% (Net Income 9.66b / Total Assets 110b)
RoE = 20.15% (Net Income TTM 9.66b / Total Stockholder Equity 47.9b)
RoCE = 14.73% (EBIT 12.8b / Capital Employed (Equity 47.9b + L.T.Debt 39.3b))
RoIC = 12.25% (NOPAT 10.00b / Invested Capital 81.6b)
WACC = 6.94% (E(195b)/V(239b) * Re(8.39%) + D(44.2b)/V(239b) * Rd(0.73%) * (1-Tc(0.22)))
Discount Rate = 8.39% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -81.96 | Cagr: -7.78%
[DCF] Terminal Value 77.97% ; FCFF base≈14.1b ; Y1≈16.2b ; Y5≈23.8b
[DCF] Fair Price = 394.8 (EV 358b - Net Debt 32.8b = Equity 325b / Shares 823.0m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 97.66 | EPS CAGR: 25.95% | SUE: 4.0 | # QB: 5
Revenue Correlation: 99.73 | Revenue CAGR: 9.43% | SUE: 0.49 | # QB: 0
EPS current Quarter (2026-10-31): EPS=3.45 | Chg30d=+0.49% | Revisions=+73% | Analysts=42
EPS current Year (2027-01-31): EPS=16.75 | Chg30d=+1.13% | Revisions=+94% | GrowthEPS=+33.8% | GrowthRev=+11.5%
EPS next Year (2028-01-31): EPS=16.02 | Chg30d=+0.60% | Revisions=+60% | GrowthEPS=-4.4% | GrowthRev=+9.7%
[Analyst] Revisions Ratio: +79% (up=116, down=12)